《药理学》课程PPT教学课件(Cardiovascular Sys)28 Agents Used in Hyperlipidemia

Agents Used in HyperlipidemiaVirtually all the lipids of humanplasma are transported as complexes withproteins. Except for fatty acids, which arebound chiefly to albumin, the lipids arecarried in special macromolecularcomplexes termed lipoproteins
1 Agents Used in Hyperlipidemia Virtually all the lipids of human plasma are transported as complexes with proteins. Except for fatty acids, which are bound chiefly to albumin, the lipids are carried in special macromolecular complexes termed lipoproteins

Definition:Hyperlipoproteinemias or HyperlipidemiasA numberof metabolic disorders thatinvolve elevations in plasma concentrationsof any of the lipoprotein species.Hyperlipemia is restricted to conditions thatinvolve increased levels of triglycerides inplasma2
2 Hyperlipoproteinemias or Hyperlipidemias: A number of metabolic disorders that involve elevations in plasma concentrations of any of the lipoprotein species. Hyperlipemia is restricted to conditions that involve increased levels of triglycerides in plasma. Definition:

Composition of the MajorLipoprotein Complexes·ChylomicronsThe low-density lipoproteins(LDL)Intermediate-density lipoproteins(IDL)Very low density lipoproteins(VLDL)High density lipoproteins (HDL)Lp(a) lipoproteins
3 Composition of the Major Lipoprotein Complexes • Chylomicrons • The low-density lipoproteins(LDL) • Intermediate-density lipoproteins(IDL) • Very low density lipoproteins(VLDL) • High density lipoproteins (HDL) • Lp(a) lipoproteins

Composition of theMajorLipoprotein ComplexesPLb%Cd%TGa%CEc%FFAe%ComplexSourceDensity (g/ml)Protein%3101-28ChylomicronIntestine1.2819901Albumin-FFAAdiposetissueaTriacylglycerols,bPhospholipids,cCholesteryl esters,dFree cholesteroleFree fatty acids*HDL2 and HDL3 derived from nascent HDL as a result of the acquisition ofcholesterylesters4
4 Complex Source Density (g/ml) Protein% TGa% PLb% CEc% Cd% FFAe % Chylomicron Intestine 1.281 9901 0 0 0 0 0 Composition of the Major Lipoprotein Complexes aTriacylglycerols, bPhospholipids, cCholesteryl esters, dFree cholesterol, eFree fatty acids *HDL2 and HDL3 derived from nascent HDL as a result of the acquisition of cholesteryl esters

Clinical seguelaeAcute pancreatitisAcute pancreatitis occurs in patients with markedhyperlipemia. In such persons, control of triglyceridelevels can prevent recurrent attacks of this life-threatening disease.AtherosclerosisIt can accelerate development ofatherosclerosisthrombus,orinfarction.Plasma lipoproteins play an essential role inatherogenesis.5
5 Clinical sequelae ❖ Acute pancreatitis Acute pancreatitis occurs in patients with marked hyperlipemia. In such persons, control of triglyceride levels can prevent recurrent attacks of this lifethreatening disease. ❖ Atherosclerosis It can accelerate development of atherosclerosis, thrombus, or infarction. Plasma lipoproteins play an essential role in atherogenesis

AtherosclerosisThecharacteristic cellular componentsinatherosclerotic plaques are foam cells,which aretransformed macrophages and smooth muscle cells thathave become filled with cholesteryl estersGlycation of lipoproteins in poorly controlleddiabetes also contributes to foam cell formationArterial hypertension accelerates atherogenesis. It iswell established that appropriate treatment of elevatedblood pressure helps to prevent coronary disease andstroke6
6 The characteristic cellular components in atherosclerotic plaques are foam cells, which are transformed macrophages and smooth muscle cells that have become filled with cholesteryl esters. Glycation of lipoproteins in poorly controlled diabetes also contributes to foam cell formation. Arterial hypertension accelerates atherogenesis. It is well established that appropriate treatment of elevated blood pressure helps to prevent coronary disease and stroke. Atherosclerosis

Atherosclerosis1.Cause(1) Those that contain apolipoprotein (apo) B100 havebeen identified as the vehicles in which cholesterol istransported into the artery wall(2) Low levels of HDL are an independent risk factor forcoronary disease(3) Cigarette smoking is a major risk factor for coronarydisease. It is associated with reduced levels of HDLimpairment of cholesterol retrieval, cytotoxic effectson the endothelium. increased oxidation ofatherogenic lipoproteins, and stimulation ofthrombogenesis
7 Atherosclerosis 1. Cause (1) Those that contain apolipoprotein (apo) B100 have been identified as the vehicles in which cholesterol is transported into the artery wall. (2) Low levels of HDL are an independent risk factor for coronary disease. (3) Cigarette smoking is a major risk factor for coronary disease. It is associated with reduced levels of HDL, impairment of cholesterol retrieval, cytotoxic effects on the endothelium, increased oxidation of atherogenic lipoproteins, and stimulation of thrombogenesis

AtherosclerosisBecause the process of atherogenesis ismultifactorial, therapy should be directed at alltheriskmodifiablefactors,includingatherogenichyperlipidemia.Therefore,thetimely diagnosis and treatment of lipoproteindisorders can be expected to decrease morbidityand mortality due to coronary disease8
8 Because the process of atherogenesis is multifactorial, therapy should be directed at all the modifiable risk factors, including atherogenic hyperlipidemia. Therefore, the timely diagnosis and treatment of lipoprotein disorders can be expected to decrease morbidity and mortality due to coronary disease. Atherosclerosis

LPATHOPHYSIOLOGYOEHYPERLIPOPROTEINEMANormal lipoprotein metabolism1.StructureTGandCEThe major lipoproteins ofplasma areparticles withhydrophobiccoreregionsApoproteincontainingcholesterylestersCholesterol1and triglycerides.Amonolayerofunesterifiedcholesterolandphospholipids surrounds thePhospholipidscore.Specific proteins(apolipoproteins)arelocatedon the surface.9
9 I. PATHOPHYSIOLOGY OF HYPERLIPOPROTEINEMIA Normal lipoprotein metabolism 1. Structure The major lipoproteins of plasma are particles with hydrophobic core regions containing cholesteryl esters and triglycerides. A monolayer of unesterified cholesterol and phospholipids surrounds the core. Specific proteins (apolipoproteins) are located on the surface

TGangCE2.Svnthesis & CatabolismApoproteinCholesterolA. Chylomicrons:PhospholipidChylomicrons, the largest of the lipoproteins, areformed in the intestine and carry triglycerides ofdietary origin. Some cholesteryl esters also appearin the chylomicron core. Phospholipids and freecholesterol-together with newly synthesized apoB48, A-I, A-II and other proteins--form the surfacemonolayer. The chylomicrons transit the thoracicduct to the blood stream10
10 2. Synthesis & Catabolism A. Chylomicrons: Chylomicrons, the largest of the lipoproteins, are formed in the intestine and carry triglycerides of dietary origin. Some cholesteryl esters also appear in the chylomicron core. Phospholipids and free cholesterol—together with newly synthesized apo B48, A-I, A-II and other proteins—form the surface monolayer. The chylomicrons transit the thoracic duct to the blood stream
按次数下载不扣除下载券;
注册用户24小时内重复下载只扣除一次;
顺序:VIP每日次数-->可用次数-->下载券;
- 《药理学》课程PPT教学课件(Central Nervous Sys)12 central nervous system stimulants.ppt
- 《药理学》课程PPT教学课件(Central Nervous Sys)17 Antiparkin.ppt
- 《药理学》课程PPT教学课件(Central Nervous Sys)13 anesthesia.ppt
- 《药理学》课程PPT教学课件(Central Nervous Sys)18 neuroleptic drugs.ppt
- 《药理学》课程PPT教学课件(Central Nervous Sys)19 opioid analgesics and antagonists.ppt
- 《药理学》课程PPT教学课件(Efferent Sys)05 the autonomic nervous system.ppt
- 《药理学》课程PPT教学课件(Efferent Sys)10 adrenergic agonists.ppt
- 《药理学》课程PPT教学课件(Efferent Sys)06 cholinergic agonists.ppt
- 《药理学》课程PPT教学课件(Efferent Sys)07 adrenergic antagonists.ppt
- 《药理学》课程PPT教学课件(Efferent Sys)12 antidepression.ppt
- 《药理学》课程PPT教学课件(抗菌药物)第三十八章 抗菌药物概论.ppt
- 《药理学》课程PPT教学课件(抗菌药物)第三十九章 β-内酰胺类抗生素.ppt
- 《药理学》课程PPT教学课件(抗菌药物)第四十一章 氨基苷类抗生素.ppt
- 《药理学》课程PPT教学课件(抗菌药物)第四十章 大环内酯类.ppt
- 《药理学》课程PPT教学课件(抗菌药物)第四十三章 人工合成类.ppt
- 《药理学》课程PPT教学课件(血液与内分泌系统药物)第三十四章 肾上腺皮质激素.ppt
- 《药理学》课程PPT教学课件(血液与内分泌系统药物)第三十三章 作用于血液及造血器官药物.ppt
- 《药理学》课程PPT教学课件(血液与内分泌系统药物)第三十六章 甲状腺激素和抗甲状腺药.ppt
- 《药理学》课程PPT教学课件(血液与内分泌系统药物)第三十五章 胰岛素及口服降血糖药.ppt
- 《药理学》课程PPT教学课件(心血管系统药物)第二十五章 抗心律失常药.ppt
- 《药理学》课程PPT教学课件(Cardiovascular Sys)27 treatment for CHF2.ppt
- 《药理学》课程PPT教学课件(Cardiovascular Sys)29 treatment for angina pectoris.ppt
- 《药理学》课程PPT教学课件(Cardiovascular Sys)20 anti-inflammation drugs.ppt
- 《药理学》课程PPT教学课件(Cardiovascular Sys)23 diuretic.ppt
- 《药理学》课程PPT教学课件(Cardiovascular Sys)25 treatment for arrthymia2.ppt
- 《药理学》课程PPT教学课件(Endocrine Sys)35 insullin.ppt
- 《药理学》课程PPT教学课件(Endocrine Sys)34 adrenocortical hormones.ppt
- 《药理学》课程PPT教学课件(Endocrine Sys)36 thyroid drugs.ppt
- 《药理学》课程PPT教学课件(Antimicrobial Drugs)43b Sulfonamides and other Synthetic Antimicrobial Drugs.ppt
- 《药理学》课程PPT教学课件(Antimicrobial Drugs)43a Quinolones and Urinary Tract Antiseptics.ppt
- 《药理学》课程PPT教学课件(Antimicrobial Drugs)41 Aminoglycosides.ppt
- 《药理学》课程PPT教学课件(Antimicrobial Drugs)42 Tetracyclines, Chloramphenicol.ppt
- 《药理学》课程PPT教学课件(Antimicrobial Drugs)38 Principles of Antimicrobial Therapy.ppt
- 《药理学》课程PPT教学课件(Antimicrobial Drugs)40 Macrolides, Lincomycin, Clindamycin.ppt
- 《药理学》课程PPT教学课件(Antimicrobial Drugs)39 Inhibitors of Cell Wall Synthesis.ppt